Rama Gangula
Last active: 12/20/2016

Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.

Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM
Cancer Cell. 2007 12 (6): 559-71

PMID: 18068632 · DOI:10.1016/j.ccr.2007.11.004

Fibroblast Growth Factor Receptor-1 (FGFR1) is commonly overexpressed in advanced prostate cancer (PCa). To investigate causality, we utilized an inducible FGFR1 (iFGFR1) prostate mouse model. Activation of iFGFR1 with chemical inducers of dimerization (CID) led to highly synchronous, step-wise progression to adenocarcinoma that is linked to an epithelial-to-mesenchymal transition (EMT). iFGFR1 inactivation by CID withdrawal led to full reversion of prostatic intraepithelial neoplasia, whereas PCa lesions became iFGFR1-independent. Gene expression profiling at distinct stages of tumor progression revealed an increase in EMT-associated Sox9 and changes in the Wnt signaling pathway, including Fzd4, which was validated in human PCa. The iFGFR1 model clearly implicates FGFR1 in PCa progression and demonstrates how CID-inducible models can help evaluate candidate molecules in tumor progression and maintenance.

MeSH Terms (21)

Animals Dimerization Disease Progression Enzyme Activation Enzyme Induction Epithelial Cells Gene Expression Regulation, Neoplastic High Mobility Group Proteins Humans Immunohistochemistry Male Mesoderm Mice Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Prostatic Neoplasms Receptor, Fibroblast Growth Factor, Type 1 Remission Induction Signal Transduction SOX9 Transcription Factor Transcription Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links